home.aspx

 
.

PHARMA PRODUCT AGGREGATION: DELIVERING BUSINESS BENEFITS BEYOND SERIALIZATION

SHARESHARESHARE
The cost of returned medicines is estimated to be between $5-10 billion per year in the US alone. However, pharmaceutical companies are struggling to streamline the data flow and verification of returned saleable goods.